The loss of IL-2 production occurred early in T cell depletion, and IL2 expression was higher in the low-risk group than in the high-risk group, which also represented a residual cytotoxicity and tumor cell clearance function of CD8+ T cells in the low-risk patients. This evidence concerns the gene IL2 and neoplasm.